Mercè Amat
Technik-/Wissenschafts-/F&E-Leiter bei Archivel Farma SL
Profil
Mercè Amat is currently the Head of Research & Development at Archivel Farma SL since 2008.
She has an undergraduate and doctorate degree from the University of Barcelona.
Aktive Positionen von Mercè Amat
Unternehmen | Position | Beginn |
---|---|---|
Archivel Farma SL
Archivel Farma SL Miscellaneous Commercial ServicesCommercial Services Archivel Farma SL provides research and development services to the pharmaceutical sector. It focuses on TB, more specifically, on the treatment of the latent TB infection diseases. The firm is association with the Germans Trias i Pujol Research Institut of Health Sciences and the Germans Trias i Pujol University Hospital has developed RUTI, the first therapeutic vaccine against TB. The company was founded in 2005 by José Martínez, Pere-Joan Cardona i Iglèsias, Jaume Amat i Reira and Isabel Amat i Riera and is headquartered in Badalona, Spain. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2008 |
Ausbildung von Mercè Amat
University of Barcelona | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Archivel Farma SL
Archivel Farma SL Miscellaneous Commercial ServicesCommercial Services Archivel Farma SL provides research and development services to the pharmaceutical sector. It focuses on TB, more specifically, on the treatment of the latent TB infection diseases. The firm is association with the Germans Trias i Pujol Research Institut of Health Sciences and the Germans Trias i Pujol University Hospital has developed RUTI, the first therapeutic vaccine against TB. The company was founded in 2005 by José Martínez, Pere-Joan Cardona i Iglèsias, Jaume Amat i Reira and Isabel Amat i Riera and is headquartered in Badalona, Spain. | Commercial Services |